Activation of Epac in the BLA disrupts reconsolidation and attenuates heroin‐seeking behaviour
Addiction Biology · 2023
DOI: 10.1111/adb.13330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction Biology, 2023. Verfasst von Shihao Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Heroin, Cocaine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The susceptibility to drug cravings evoked by stimuli poses a formidable hurdle in the treatment of addiction and the prevention of relapse. Pharmacological interventions targeting drug‐associated memories hold promise for curbing relapse by impeding the process of memory reconsolidation, predominantly governed by cAMP signalling. Exchange Protein Activated by cAMP (Epac) serves as a distinctive mediator of cAMP signalling, which has been implicated in reinforcing the effects of cocaine and facilitating the acquisition. Nonetheless, the role of Epac in heroin‐related memory and the subsequent seeking behaviour remains enigmatic. In this study, we explored the impact of Epac activation on the reconsolidation process of drug‐related memories associated with heroin self‐administration. Over the course of 10 consecutive days, rats underwent training, wherein they acquired the behaviour of nose poking to obtain heroin accompanied by a tone + light cue. This nose‐poking behaviour was subsequently extinguished when heroin infusion and cue presentation were discontinued. Subsequently, we administered 8‐pCPT‐cAMP (8‐CPT), an Epac‐specific activator, into the basolateral amygdala at various time points, either in the presence or absence of a conditioned stimulus. Our findings demonstrate that administering 8‐CPT immediately after memory retrieval effectively reduces cue‐ and heroin‐induced reinstatement, with the observed effects persisting significantly for a minimum of 28 days. However, infusion of 8‐CPT for a duration of 6 h following the memory retrieval trial, or without it altogether, had no discernible impact. Thus, these findings strongly suggest that Epac activation can disrupt the reconsolidation of heroin‐associated memory, thereby diminishing the reinstatement of heroin‐seeking behaviour.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, China.
- Department of Neurobiology, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
- Key Laboratory of Molecular Epidemiology of Hunan Province, School of Medicine, Hunan Normal University, Changsha, China.
- Xinxiang Medical University, Xinxiang, Henan, China.
- Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China.
- Clinical and Translational Sciences Lab, The Douglas Research Centre, McGill University, Montreal, Canada.
ORCID-Profile: Shihao Huang, Yiwei Liao
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, S., Shi, C., Liu, F., Si, Y., Shen, D., Yang, L., Gao, Y., & Liao, Y. (2023). Activation of Epac in the BLA disrupts reconsolidation and attenuates heroin‐seeking behaviour. Addiction Biology. https://doi.org/10.1111/adb.13330
Vancouver
Huang S, Shi C, Liu F, Si Y, Shen D, Yang L, et al. Activation of Epac in the BLA disrupts reconsolidation and attenuates heroin‐seeking behaviour. Addiction Biology. 2023. doi:10.1111/adb.13330
BibTeX
@article{Huang2023,
author = {Huang, Shihao and Shi, Cuijie and Liu, Fanglin and Si, Yue and Shen, Dan and Yang, Liping and Gao, Yujun and Liao, Yiwei},
title = {Activation of Epac in the BLA disrupts reconsolidation and attenuates heroin‐seeking behaviour},
journal = {Addiction Biology},
year = {2023},
doi = {10.1111/adb.13330}
}
EUVIMED